Adaptive Biotechnologies Corporation
ADPT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $883 | $707 | $1,089 | $3,938 |
| - Cash | $48 | $65 | $90 | $139 |
| + Debt | $89 | $99 | $108 | $112 |
| Enterprise Value | $924 | $741 | $1,107 | $3,911 |
| Revenue | $179 | $170 | $185 | $154 |
| % Growth | 5.1% | -8.1% | 20.1% | – |
| Gross Profit | $107 | $95 | $127 | $105 |
| % Margin | 59.7% | 55.6% | 68.7% | 68.1% |
| EBITDA | -$129 | -$189 | -$175 | -$193 |
| % Margin | -71.9% | -111.2% | -94.6% | -125.3% |
| Net Income | -$159 | -$225 | -$200 | -$207 |
| % Margin | -89.1% | -132.3% | -108% | -134.3% |
| EPS Diluted | -1.08 | -1.56 | -1 | -1.46 |
| % Growth | 30.8% | -56% | 31.5% | – |
| Operating Cash Flow | -$95 | -$156 | -$184 | -$193 |
| Capital Expenditures | -$4 | -$11 | -$16 | -$62 |
| Free Cash Flow | -$99 | -$167 | -$200 | -$254 |